Meet Israel’s biomedical innovation and healthcare at the ILSI-Biomed! ADDS will participate along with its network of expertise, Convergence. Dr. Irčne FERMONT, VP Pharmacovigilance & Risk Management, will give a presentation on ‘EMA Safety Requirements: From Clinical trials to Marketing Authorization – Risk Management Plan, EU Pharmacovigilance System, Advanced Therapies’ (June 15, 2010, 17:20pm - 18:20pm). ADDS is happy to convene you to a Networking session and cocktail from 4pm to 6pm at the Israel Export Institute.